Aug 08, 2024 / 12:30PM GMT
Operator
Good morning, and welcome to Novavax second-quarter 2024 financial results and operational highlights conference call. (Operator Instructions). Please note, this event is being recorded.
I would now like to turn the call over to your speaker today, Erika Schultz, Senior Director, Investor Relations. Please go ahead.
Erika Schultz - Novavax Inc - Senior Director, Investor Relations
Good morning, and thank you, all, for joining us today to discuss our second-quarter 2024 operational highlights and financial results. A press release announcing our results is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today.
Please turn to slide 2. Before we begin with prepared remarks, I need to remind you that this presentation includes forward-looking statements, including information relating to the future of Novavax; its key strategic priorities; statements related to potential royalties and milestones; operating plans, objectives, and prospects; full-year 2024
Q2 2024 Novavax Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot